← 홈

제2형 당뇨 · IL-4R

3개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-14 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3개
AntibodySHOTFDACuratedFDABiologicNovo NordiskeffectsApproved

semaglutide (Ozempic / Wegovy, GLP-1, Wegovy, NN9535)

Type 2 diabetes, chronic weight management, CV risk reduction (T2D) · GLP-1 receptor

#GLP-1receptor#Antibody#Approved#FDA승인#바이오모아추천+5
효능 Weight ↓14.9%임상시험 141상태 APPROVED
AntibodySHOTFDACuratedFDABiologicEli LillyApproved

tirzepatide (Mounjaro / Zepbound, Mounjaro, Zepbound, LY3298176)

Type 2 diabetes, chronic weight management · GLP-1 / GIP receptor

#GLP-1GIPreceptor#Antibody#Approved#FDA승인#바이오모아추천+5
효능 HbA1c ↓2.4%임상시험 117상태 APPROVED
CGTBiologicstaleThe Affiliated Hospital of Xuzh…Preclinical

GLP-1 receptor agonist (GLP-1 receptor agonist)

Type 2 Diabetes Mellitus · Type 2 Diabetes Mellitus

#Type2DiabetesMellitus#CGT#Preclinical#세포유전치료#CAR-T+2
효능 ORR 1.03%임상시험 1상태 ACTIVE